Bita MESGARPOUR

Publications

Articles

1. Sofi-Mahmudi A, Shamsoddin E, Ghasemi P, Nasser M, Mesgarpour B. Assessing Google Searches for Toothache during COVID-19 Lockdowns. Medical Journal of The Islamic Republic of Iran (MJIRI). 2023;37(1):282-93.
2. Mesgarpour B, Sadeghirad B. Cochrane in CORR®: Reducing Medication Errors for Adults in Hospital Settings. Clinical Orthopaedics and Related Research® 2022:10-97.
3. Khalili M, Sharifi H, Mesgarpour B, Kheirandish M, Olsson S, Javidnikou N, Haghdoost AA. Evaluation of pharmacovigilance system in Iran. International Journal of Health Policy and Management 2022;11(7):990-1000.
4. Mohsenzadeh P, Ardekani A, Poustchi H, Mohammadi Z, Abdipour Mehrian SR, Bazrafshan Drissi H, Rahimian Z, Taherifard E, Nabavizadeh A, Kamalipour A, Mesgarpour B, Malekzadeh F, Molavi Vardanjani H. Population-based pattern of medication use and prevalence of polypharmacy among patients with cardiovascular diseases: results of the Pars cohort study from Iran. BMC Cardiovasc Disord 2022; 22: 435
5. Kabir A, Sofi-Mahmudi A, Karimi Behnagh A, Eidkhani V, Baradaran HR, , Kabiri P, Haghdoost A, Mesgarpour B. Risk of Bias in Iranian Randomized Trials Included in Cochrane Reviews. Archives of Iranian Medicine 2022; 25(6): 375-382.
6. Yazdizadeh B, Ehsani-Chimeh E, Zendehdel K, Mobinizadeh M, Mesgarpour B, Fakoorfard Z. Knowledge gaps and national research priorities for COVID-19 in Iran. Health Research Policy and Systems 2022; 20(1): 1-4.
7. Hatami H, Sotgiu G, Bostanghadiri N, Abadi SS, Mesgarpour B, Goudarzi H, Migliori GB, Nasiri MJ. Bedaquiline-containing regimens and multidrug-resistant tuberculosis: a systematic review and meta-analysis. Jornal Brasileiro de Pneumologia 2022; 48(2).
8. Sofi-Mahmudi, A., Shamsoddin, E., Mesgarpour, B., Akhondzadeh, S., Kabiri, P. Investigating gender differences in research performance of Iranian medical faculty members: A scientometric study. Tehran University Medical Journal 2021; 79(7): 546-555 (Persian)
9. Khalili M, Mesgarpour B, Sharifi H, Golozar A, Haghdoost AA. Estimation of adverse drug reaction reporting in Iran: Correction for underreporting. Pharmacoepidemiology and Drug Safety 2021; 30(8): 1101-1114
10. Shamsoddin E, Torkashvand-Khah Z, Sofi-Mahmudi A, Janani L, Kabiri P, Shamsi-Gooshki E, Mesgarpour B. Assessing research misconduct in Iran: a perspective from Iranian medical faculty members. BMC Medical Ethics 2021; 22(1): 74
11. Sofi-Mahmudi A, Iranparvar P, Shakiba M, Shamsoddin E, Mohammad-Rahimi H, Naseri S, Motie P, Tovani-Palone MR, Mesgarpour B. Quality assessment of studies included in Cochrane oral health systematic reviews: A meta-research. International Journal of Environmental Research and Public Health 2021; 18 (14)
12. Dehghani M, Mesgarpour B, Akhondzadeh S, Azami-Aghdash S, Ferdousi R. How the US sanctions are affecting the health research system in Iran? Archives of Iranian Medicine 2021; 24(2): 101-106
13. Smith CA, Collins CT, Levett, KM, Armour M, Dahlen HG, Tan AL, Mesgarpour B. Acupuncture or acupressure for pain management during labour. Cochrane Database of Systematic Reviews, 2020(2): CD009232
14. Moazen-Zadeh E, Bayanati S, Ziafat K, Rezaei F, Mesgarpour B, Akhondzadeh S. Vortioxetine as adjunctive therapy to risperidone for treatment of patients with chronic schizophrenia: A randomised, double-blind, placebo-controlled clinical trial. Journal of Psychopharmacology 2020; 34(5): 506-513
15. Yazdizadeh B, Majdzadeh R, Ahmadi A, Mesgarpour B. Health research system resilience: lesson learned from the COVID-19 crisis. Health Research Policy and Systems 2020; 18(1),136
16. Dehghani M, Akhondzadeh S, Mesgarpour B, Ferdousi R. A tool to reduce the problems of Iranian health researchers. Iranian Journal of Public Health 2020; 49(12), pp. 2441-2442
17. Khalili M, Mesgarpour B, Sharifi H, Daneshvar Dehnavi S, Haghdoost AA. Interventions to improve adverse drug reaction reporting: A scoping review. Pharmacoepidemiology and Drug Safety 2020; 29(9): 965-992
18. Mesgarpour B, Aghababa S, Baradaran HR, Kabiri P, Kabir A, Sofi-Mahmudi A, Haghdoost AA. Achievements of the Cochrane Iran Associate Centre: Lessons learned. International Journal of Health Policy and Management 2020; 9(6): 222-228
19. Shamsoddin E, Janani L, Ghamari K, Kabiri P, Shamsi Gooshki E, Mesgarpour B. Psychometric properties of ft he version of the research misconduct questionnaire (Prmq). Journal of Medical Ethics and History of Medicine 2020; 13: 1-13
20. Khalili M, Sharifi H, Mesgarpour B, Kheirandish M, Olsson S, Javidnikou N, Haghdoost AA. Evaluation of Pharmacovigilance System in Iran. International Journal of Health Policy and Management 2020; 1-11
21. Dehghani M, Akhondzadeh S, Mesgarpour B, Ferdousi R. Design and implementation of a social network for laboratory researchers. Iranian Red Crescent Medical Journal 2020, 22 (10)
22. Hajizadeh-Zaker R, Ghajar A, Mesgarpour B, Afarideh M, Mohammadi MR, Akhondzadeh S. L-Carnosine As an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial. Journal of Child and Adolescent Psychopharmacology 2018; 28(1): 74-81.
23. Mesgarpour B, Heidinger BH, Roth D, Schmitz S, Walsh CD, Herkner H. S. Harms of off-label erythropoiesis stimulating agents for critically ill patients. Cochrane Database of Systematic Reviews 2017; 2017(8): CD010969
24. Hajarizadeh B, Mesgarpour B, Nasiri MJ, Alavian SM, Merat S, Poustchi H, Malekzadeh R, Sedaghat A, Haghdoost AA. Estimating the prevalence of hepatitis B virus infection and exposure among general population in Iran. Hepatitis Monthly 2017; 17(8): e11715
25. Arabzadeh S, Shahhossenie M, Mesgarpour B, Rezaei F, Shalbafan MR, Ghiasi Z, Akhondzadeh, S. L-carnosine as an adjuvant to fluvoxamine in treatment of obsessive compulsive disorder: A randomized double-blind study. Human Psychopharmacology 2017; 32(4):e2584
26. Rezaei F, Mesgarpour B, Jeddian A, Zeionoddini A, Mohammadinejad P, Salardini E, Shahriari M, Zeinoddini A, Akhondzadeh S. Cilostazol adjunctive therapy in treatment of negative symptoms in chronic schizophrenia: Randomized, double-blind, placebo-controlled study. Human Psychopharmacology 2017; 32(4):e2583
27. Esalatmanesh S, Biuseh M, Noorbala AA, Mostafavi SA, Rezaei F, Mesgarpour B, Mohammadinejad, P, Akhondzadeh S. Comparison of saffron and fluvoxamine in the treatment of mild to moderate obsessive-compulsive disorder: A double blind, randomized clinical trial. Iranian Journal of Psychiatry 2017; 12(3): 154-162.
28. Desai RJ, Thaler KJ, Mahlknecht P, Gartlehner G, McDonagh MS, Mesgarpour B, Mazinanian A, Glechner A, Gopalakrishnan C, Hansen RA. Comparative Risk of Harm Associated With the Use of Targeted Immunomodulators: A Systematic Review. Arthritis Care Research (Hoboken). 2016 Aug;68(8):1078-88. doi: 10.1002/acr.22815.
29. Mesgarpour B, Mesgarpour M, Herkner H. SensPrecOptimizer: a software tool that combined search queries to design efficient search strategies. Journal of Clinical Epidemiology 2016; 71:122-3.
30. Mesgarpour B, Gouya G, Herkner H, Reichardt B, Wolzt M. A population-based analysis of the risk of drug interaction between clarithromycin and statins for hospitalisation or death. Lipids Health Disease. 2015 Oct 24;14:131. doi: 10.1186/s12944-015-0134-y.
31. Mesgarpour B, Griebler U, Glechner A, Kien C, Strobelberger M, Van Noord MG, Michalek-Sauberer A. Extended-release opioids in the management of cancer pain: A systematic review of efficacy and safety. European Journal of Pain 2013 Sep 20. doi: 10.1002/j.1532-2149.2013.00401.x
32. Mesgarpour B, Heidinger BH, Schwameis M, Kienbacher C, Walsh C, Schmitz S, Herkner H. Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. Intensive Care Medicine 2013; 39(11): 1896-1908.
33. Mesgarpour B, Müller M, Herkner H. Search strategies to identify reports on “off-label” drug use in EMBASE. BMC Medical Research Methodology 2012; 12:190.
34. Mesgarpour B, Müller M, Herkner H. Search strategies-identified reports on ‘‘off-label’’ drug use in MEDLINE. Journal of Clinical Epidemiology 2012; 65: 827-834.
35. Mesgarpour B, Kabiri P, Vasei M, Nasiri I, Aminpour F, Bamdadi F. Attitudes of Academic Members of Iranian Medical Universities towards Factors that Increase h-index and Paper Citations. Hakim Research Journal 2011; 14(3): 130- 136 (Persian).
36. Mesgarpour B, Vasei M, Kabiri P, Alavi M, Aminpour F, Kamalian M, Bamdadi F. The Comparison of National, Regional and International Webometric Ranks of Iranian Universities and Research Centers. Hakim Research Journal 2009; 12 (3): 18-29 (Persian).
37. Merat S, Khatibzadeh S, Mesgarpour B, Malekzadeh R. A survey of the current status of web-based databases indexing Iranian journals. Archives of Iranian medicine 2009; 12(3): 271-8.
38. Mesgarpour B, Etemadi A, Fotouhi A, Kebriaeezadeh A, Younesian M. The Trend of Pharmaceutical Research in Iran Compared to Middle East and North Africa: A Scientometrics Study. Health Information Management 2009; 6(2): 141-151 (Persian).
39. Mirzazadeh A, Hajarizadeh B, Mesgarpour B, Golozar A, Holakouie Naieni K. Mapping of Cutaneous Leishmaniosis in Kerman City from 2002 to 2006 and its Environmental Risk Factors by Geographical Information System. Iranian Journal of Epidemiology 2009;4(3-4): 17-25 (Persian).
40. Sedighi ZH, Majdzadeh SR, Nejat SN, Fotouhi A, Shahidzadeh A, Gholami ZH, Younesian M, Rashidian A,Mesgarpour B, Etemadi A, Yazdani K. Knowledge translation: A model for research utilization. Payesh2008; 7(1): 35-47 (Persian). [SID Abstract]
41. Ghanei M, Mesgarpour B, Saadat SH, Parsapour A, Bamdadi F, Robati AM, Keramati A. Executive management of bioethics in medical researches: The results of "making research ethics codes practical from different management sides in medical researches" workshop at Nov 2006. Journal of Medical Ethics and History of Medicine 2008; 1:2 (Persian).
42. Farhoudian A, Sharifi V, Amini H, Basirnia A, Mesgarpour B, Mansouri N, Amin-Esmaeeli M, Salesian N, Mohammadi MR, Yousefi-Nooraie R, Rahimi Movaghar A. Prevalence of psychiatric disorders in Iran: A systematic review. Iranian Journal of Psychiatry 2007; 2(4): 137-150.
43. Basirnia A, Sharifi V, Mansouri N, Mesgarpour B, Mohammadi MR, Amini H, Farhoudian A, Yousefi-Nooraie R, Rahimi Movaghar A. Prevalence of Mental Disorders among High-School Students in Iran: A Systematic Review. Iranian Journal of Psychiatry 2009; 4(1): 1-6.
44. Adhami HR, Mesgarpour B, Farsam H. Herbal Medicine in Iran. HerbalGram: The Journal of American Botanical Council 2007; 74: 34- 43.
45. Mohammadi MR, Ghanizadeh A, Mohammadi M, Mesgarpour B. Prevalence of social phobia and its comorbidity with psychiatric disorders in Iran. Depression and Anxiety 2006; 23(7): 405- 411. [PubMed]
46. Mohammadi MR, Ghanizadeh A, Davidian H, Noorbala AA, Malekafzali H, Naghavi HR, Pouretemad HR, Bagheri Yazdi SA, Rahgozar M, Alaghebandrad J, Amini H, Razzaghi EM, Mesgarpour B, Mohammadi M, Ghaemi SN. Prevalence of Mood Disorders in Iran. Iranian Journal of Psychiatry 2006; 1(2): 59-64.
47. Khalaj A, Shokraiee K, Seyfi P, Mesgarpour B, Adhami HR. Qualitative assessment of the views of graduate and undergraduate students of the faculty of pharmacy about pharmaceutical research in Iran. Hakim Research Journal 2006; 9(1): 45-51 (Persian). [SID Abstract]
48. Mohammadi MR, Davidian H, Noorbala AA, Malekafzali H, Naghavi HR, Pouretemad HR, Bagheri Yazdi SA, Rahgozar M, Alaghebandrad J, Amini H, Razzaghi EM, Mesgarpour B, Soori H, Mohammadi M, Ghanizadeh A. An epidemiological survey of psychiatric disorders in Iran. Clinical Practice and Epidemiology in Mental Health 2005; 1:16. [PubMed]
49. Mohammadi MR, Mesgarpour B, Daliri Hampa A, Izadian ES, Adhami HR. Consuming and prescribing psychotherapeutic medications in elderly. Journal of Rehabilitation 2005; 59-69. (Persian) [SID Abstract]
50. Mohammadi MR, Ghanizadeh A, Alaghband-rad J, Tehranidoost M, Mesgarpour B, Soori H. Selegiline in comparison with methylphenidate in attention deficit hyperactivity disorder children and adolescents in the double-blind, randomized clinical trial. Journal of Child and Adolescent Psychopharmacology 2004; 14(3): 426-433. [PubMed]
51. Mohammadi MR, Ghanizadeh A, Rahgozar M, Noorbala AA, Davidian H, Afzali HM, Naghavi HR, Yazdi SA, Saberi SM, Mesgarpour B, Akhondzadeh S, Alaghebandrad J, Tehranidoost M. Prevalence of obsessive-compulsive disorder in Iran. BMC Psychiatry 2004 Feb 14; 4:2. [PubMed]
52. Mohammadi MR, Rahgozar M, Bagheri Yazdi A, Naghavi HR, Pouretemad HR, Amini H, Rostami MR, Khalajabadi Farahani F, Mesgarpour B. Epidemiological Study of Psychiatric Disorders in Tehran Province. Iranian Journal of Psychiatry and Clinical Psychology 2003; 9(2(34):4-14 (Persian).
53. Sahimi-Izadian E, Ahmadi Abhari SA, Mesgarpour B. Efficacy and safety of Trazodone vs. Nortriptyline among middle aged patients with major depression. Advances in Cognitive Science 2003; 5(1): 21-26. (Persian)
54. Amanlou M, Mesgarpour B, Farsam H. Determination of ginkgolides A and B in Ginkgo biloba leaves by HPLC using activated charcoal. Daru 2003; 10(4): 171-179.
55. Mohammadi MR, Mesgarpour B. Systemic approach to health research in Iran and the world. Hakim Research Journal 2002; 5(2): 151-167. (Persian) [SID Abstract]

Books

1. Mesgarpour B, Ghasabian A. Trend and Situation Analysis of Health Patents Registration in Iran, Middle East and the World. Tehran University of Medical Sciences Press; Tehran, Iran. 2008 [ISBN: 978-964-894-173-6]
2. Mesgarpour B. Iranian Herbal Medicine. Shahraz S and Ghaziani T. In: IRANPHARMA: A comprehensive Textbook of Drug Information. 2nd Ed., Teimourzadeh Press; Tehran, Iran. 2008, pp: 816-860. [ISBN: 978-964-420-520-0]
3. Mohammadi MR, Mesgarpour B, Izadian ES, Mohammadi M. Psychological and psychopharmacological tests in children and adolescents. Teimourzadeh Press; Tehran, Iran. 2007 [ISBN: 964-420-403-4]
4. Ziaie A, Mesgarpour B. Herbal Medicine: Evidence Based Contraindication and Drug Interactions. Teimourzadeh Press; Tehran, Iran. 2005 [ISBN: 964-456-902-4]
5. Mesgarpour B. Iranian Herbal Medicine. Shahraz S and Ghaziani T. In: IRANPHARMA: A comprehensive Textbook of Drug Information (Handbook). Teimourzadeh Press; Tehran, Iran. 2005 [ISBN: 964-420-260-0]
6. Mesgarpour B. Iranian Herbal Medicine. Shahraz S and Ghaziani T. In: IRANPHARMA: A comprehensive Textbook of Drug Information. 1st Ed., Teimourzadeh Press; Tehran, Iran. 2002, pp: 748-780. [ISBN: 964-456-639-4]